Rebalance LLC bought a new position in iShares iBonds Dec 2027 Term Corporate ETF (NYSEARCA:IBDS – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 358,509 shares of the company’s stock, valued at approximately $8,590,000. iShares iBonds Dec 2027 Term Corporate ETF accounts for 0.6% of Rebalance LLC’s holdings, making the stock its 16th largest holding. Rebalance LLC owned approximately 0.37% of iShares iBonds Dec 2027 Term Corporate ETF as of its most recent SEC filing.
A number of other hedge funds also recently made changes to their positions in the company. Crews Bank & Trust purchased a new position in iShares iBonds Dec 2027 Term Corporate ETF in the fourth quarter valued at about $3,960,000. Centricity Wealth Management LLC bought a new stake in shares of iShares iBonds Dec 2027 Term Corporate ETF during the fourth quarter valued at about $3,947,000. Sonata Capital Group Inc. boosted its holdings in shares of iShares iBonds Dec 2027 Term Corporate ETF by 197.4% in the fourth quarter. Sonata Capital Group Inc. now owns 204,751 shares of the company’s stock valued at $4,906,000 after acquiring an additional 135,902 shares in the last quarter. Spinnaker Trust lifted its holdings in shares of iShares iBonds Dec 2027 Term Corporate ETF by 53.0% in the fourth quarter. Spinnaker Trust now owns 373,877 shares of the company’s stock valued at $8,958,000 after buying an additional 129,587 shares during the period. Finally, Captrust Financial Advisors grew its stake in shares of iShares iBonds Dec 2027 Term Corporate ETF by 36.4% in the 3rd quarter. Captrust Financial Advisors now owns 414,425 shares of the company’s stock worth $10,100,000 after purchasing an additional 110,597 shares during the last quarter.
iShares iBonds Dec 2027 Term Corporate ETF Stock Down 0.1 %
Shares of iShares iBonds Dec 2027 Term Corporate ETF stock opened at $24.08 on Monday. iShares iBonds Dec 2027 Term Corporate ETF has a 12-month low of $23.44 and a 12-month high of $24.68. The stock’s fifty day moving average is $24.02 and its 200-day moving average is $24.10.
About iShares iBonds Dec 2027 Term Corporate ETF
The iShares iBonds Dec 2027 Term Corporate ETF (IBDS) is an exchange-traded fund that mostly invests in investment grade fixed income. The fund tracks a Bloomberg global index of USD-denominated, investment-grade corporate bonds maturing between December 31, 2026 and December 16, 2027. IBDS was launched on Sep 12, 2017 and is managed by BlackRock.
See Also
- Five stocks we like better than iShares iBonds Dec 2027 Term Corporate ETF
- Pros And Cons Of Monthly Dividend Stocks
- Institutional Investors Bet $1B on These 4 Stocks—Should You?
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- One Must-Buy Stock and One to Avoid as Tariffs Shake the Market
- 5 Top Rated Dividend Stocks to Consider
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
Receive News & Ratings for iShares iBonds Dec 2027 Term Corporate ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares iBonds Dec 2027 Term Corporate ETF and related companies with MarketBeat.com's FREE daily email newsletter.